Journal  —  Vendor reviews

What makes a vendor COA worth reading

Not all certificates of analysis carry the same weight. A short guide to the lines that matter, and the ones to skip.

By@vendor-opsJuly 8, 2026 · 6 min readVendor reviews

What the lab actually tells you

Reading a COA

Every reputable peptide vendor publishes a certificate of analysis. Reading one well is a 90-second skill that filters most of the bad supply out of your funnel.

What a COA is (and isn't)

A COA is the third-party lab's report on a specific batch of a specific compound. It is not a manufacturer self-attestation, it is not a marketing document, and it is not transferable between batches. The page reads dry on purpose — its job is to be checkable.

  • Compound identity (mass spectrometry, HPLC).
  • Purity percentage and the impurity profile.
  • Net peptide content — not the same as bottle weight.
  • Batch ID and the date the assay was run.

Three things to actually check

  1. Match the batch ID on the COA to the batch ID on your vial. If they don't match, the document is decorative.
  2. Confirm the lab is independent. A COA on the vendor's letterhead is a self-assessment, not a third-party assay.
  3. Read the impurity profile, not just the headline purity number. A 98% number with three named impurities is more useful than a 99% number with no breakout.

If a vendor won't publish the impurity breakdown, the purity number on its own isn't telling you what you think it is.

Common COA red flags

Stale dates. Same COA across multiple batches. No lab name. Net peptide content missing or quietly removed. PDF that resists copy-paste (a tell that the document was rasterized to hide a field). None of these are dispositive — taken together they are.

REL/02 —  Keep reading

From the desk.

All posts

Jul 14, 2026 · 4 min

Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight loss - Nature

A Nature analysis suggests cardioprotective effects track the dose patients actually sustain rather than the pounds they drop, with implications for GLP-1 dosing strategies.

@peptidedesk

Jul 14, 2026 · 4 min

FDA Accepts Sandoz Generic Tirzepatide Applications Amid Biosimilar Development Gap - Center for Biosimilars

Sandoz's accepted FDA applications for generic tirzepatide signal potential competition in the GLP-1 market, though a broader biosimilar development gap persists.

@peptidedesk

Jul 14, 2026 · 4 min

Tirzepatide vs. Semaglutide: What You Should Know - Cleveland Clinic Health Essentials

Cleveland Clinic publishes an educational overview comparing the two dominant GLP-1 receptor agonists, breaking down differences in mechanism, efficacy, and clinical context for patients and researchers tracking metabolic peptide developments.

@peptidedesk

Jul 14, 2026 · 4 min

Effectiveness and Safety of Combined Semaglutide and Dapagliflozin Therapy in Type 2 Diabetes: A Retrospective Cohort Study - Cureus

A retrospective Cureus study adds real-world data on pairing a GLP-1 receptor agonist with an SGLT2 inhibitor for type 2 diabetes.

@peptidedesk

Jul 14, 2026 · 4 min

Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial

A reported Phase 3 readout for a GLP-3 receptor agonist hints at a next-generation metabolic peptide class. The data is preliminary and sourced through a single news aggregator—here is what is actually known.

@peptidedesk

Jul 14, 2026 · 4 min

Two Preventable Semaglutide Dosing Errors May Have Driven a Surge in Poison Control Calls - Discover Magazine

A Discover Magazine report ties a spike in poison control calls to two avoidable semaglutide measurement mistakes, underscoring safety risks as compounded and research-grade GLP-1 products circulate widely.

@peptidedesk

006 —  The drops

Keep browsing live,
verified coupon drops.

Compare active codes by vendor and category now. Account alerts will ship only after the watchlist flow is ready.

Public codes · Direct vendor checkout · Research use only

001 — Independent

We don't list what we wouldn't research.

SavePeptides lists vendors after an initial review and distinguishes verified vendors where additional checks have been completed. We may earn commissions from referral links, and sponsored placements will be clearly disclosed.

002 — Vendor-funded

Free to browse. Supported by referrals.

SavePeptides is free for buyers. We may earn a commission when you order through our links, but we do not lock deals behind a paywall, require an email to view codes, or inflate comparison prices.

003 — Research use

Research-use disclaimer.

SavePeptides surfaces vendor, pricing, and coupon information for research compounds. These products are not intended, approved, or recommended for human consumption. Our content is informational only and does not constitute medical advice.